Connect with us

Hi, what are you looking for?

Big Wealth DailyBig Wealth Daily

Investing

Canadian Investment Regulatory Organization Trade Resumption – PRIZ

Published

 

 

Trading resumes in:

 

Company:  Prismo Metals Inc.  

 

CSE Symbol: PRIZ  

 

All Issues: Yes  

 

Resumption (ET):   8:00 AM   7/21/2025   

 

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada .

 

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

 

 

 

  View original content: http://www.newswire.ca/en/releases/archive/July2025/18/c4294.html  

 

 

 

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

In this article:

You May Also Like

Stock

Major Shift in the Markets! Here’s Where the New Strength Is

In this video, Mary Ellen spotlights breakouts in Energy and Defense, Technology sector leadership, S&P 500 resilience, and more. She then unpacks the stablecoin...

June 17, 2025

Stock

RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New Rally?

This week, Julius breaks down the current sector rotation using his signature Relative Rotation Graphs, with XLK vaulting into the leading quadrant while utilities...

June 21, 2025

Stock

Fibonacci Retracements: The Key to Identifying True Breakouts

If you’ve looked at enough charts over time, you start to recognize classic patterns that often appear. From head-and-shoulders tops to cup-and-handle patterns, they...

June 28, 2025

Investing

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated...

June 24, 2025